bluebird bio, one of the stocks in my personal biote basket. It got crushed on monday, down about 25 % in one day. The fda paused one of its gentherapy studies due to concerns that one of its therapies contributed to a patient getting cancer. Even though the stock got crushed, that basket as a whole was actually up on the day.
Disney’s blowout 3rd quarter is fueled by growth in Disney+ subscribers. Airbnb predicts record revenue on the horizon. Unity Software’s 2nd-quarter report calms shareholder concerns. Boston Beer and Pepsi team up to create an alcoholic version of Mountain Dew. Jason Moser and Ron Gross analyze those stories, discuss the latest from eBay, Chegg, DoorDash, and The Trade Desk, and share two stocks on their radar: Outset Medical and bluebird bio.
Plus, Motley Fool analyst Maria Gallagher talks with Julia Galef about her book, The Scout Mindset: Why Some People See Things Clearly and Others Don’t.
Learn more about your ad choices. Visit megaphone.fm/adchoices